Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence

Magn Reson Imaging. 1993;11(4):509-19. doi: 10.1016/0730-725x(93)90470-x.

Abstract

The ability of superparamagnetic iron oxides (SPIO) and ultrasmall superparamagnetic iron oxides (USPIO) to act as positive contrast enhancers due to a marked T1 relaxivity was investigated. At low concentrations, an important signal enhancement was observed in vitro, reaching 120% for SPIO and 140% for USPIO in a spin echo 500/22 sequence. The more heavily the sequence was T1-weighted the greater the enhancement. As the concentration increased, the signal dropped. The in vivo study of USPIO in the rat showed that at low doses (14 mumol Fe/kg), the myocardial signal was enhanced by 30%, whereas at high doses (77 mumol Fe/kg), it fell by -50%. These results indicate that in T1-weighted spin echo sequences, the MR signal can be enhanced by low concentrations of superparamagnetic compounds. This effect could be useful in perfusion imaging, and is also important for a better understanding of any possible paradoxical positive enhancement which could occur in perfused organs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Contrast Media*
  • Dextrans
  • Ferrosoferric Oxide
  • Heart / anatomy & histology*
  • Humans
  • Image Enhancement / methods
  • In Vitro Techniques
  • Iron*
  • Liver / anatomy & histology*
  • Magnetic Resonance Imaging*
  • Magnetite Nanoparticles
  • Male
  • Models, Structural
  • Oxides*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Contrast Media
  • Dextrans
  • Magnetite Nanoparticles
  • Oxides
  • ferumoxtran-10
  • Iron
  • ferumoxides
  • Ferrosoferric Oxide